EMD SERONO FDA Approval BLA 021684

BLA 021684

EMD SERONO

FDA Drug Application

Application #021684

Documents

Letter2020-03-23
Letter2020-03-23
Label2020-03-23
Letter2020-03-23
Label2020-03-23
Label2020-03-23
Review2020-03-23
Other2020-03-23

Application Sponsors

BLA 021684EMD SERONO

Marketing Status

Prescription001
Prescription002
Prescription003
Prescription004

Application Products

001INJECTABLE;SUBCUTANEOUS300 IU/0.5ML0GONAL-F RFF REDI-JECTFOLLITROPIN ALFA/BETA
002INJECTABLE;SUBCUTANEOUS450 IU/0.75ML0GONAL-F RFF REDI-JECTFOLLITROPIN ALFA/BETA
003INJECTABLE;SUBCUTANEOUS900 IU/1.5ML0GONAL-F RFF REDI-JECTFOLLITROPIN ALFA/BETA
004INJECTABLE;SUBCUTANEOUS150 IU/0.25ML0GONAL-F RFF REDI-JECTFOLLITROPIN ALFA/BETA

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2004-05-25STANDARD
LABELING; LabelingSUPPL7AP2007-12-18STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL8AP2007-12-06N/A
MANUF (CMC); Manufacturing (CMC)SUPPL19AP2013-01-11STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL23AP2013-02-06STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL24AP2013-01-23STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL25AP2013-01-31STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL27AP2013-02-08STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL28AP2013-02-14STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL29AP2013-02-19STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL33AP2013-04-04STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL36AP2013-10-16N/A
MANUF (CMC); Manufacturing (CMC)SUPPL38AP2017-11-06N/A

Submissions Property Types

SUPPL19Null0
SUPPL23Null0
SUPPL24Null0
SUPPL25Null0
SUPPL27Null0
SUPPL28Null0
SUPPL29Null0
SUPPL33Null0
SUPPL36Null15
SUPPL38Null6

CDER Filings

EMD SERONO
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21684
            [companyName] => EMD SERONO
            [docInserts] => ["",""]
            [products] => [{"drugName":"GONAL-F RFF REDI-JECT","activeIngredients":"FOLLITROPIN ALFA\/BETA","strength":"300 IU\/0.5ML","dosageForm":"INJECTABLE;SUBCUTANEOUS","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"GONAL-F RFF REDI-JECT","activeIngredients":"FOLLITROPIN ALFA\/BETA","strength":"450 IU\/0.75ML","dosageForm":"INJECTABLE;SUBCUTANEOUS","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"GONAL-F RFF REDI-JECT","activeIngredients":"FOLLITROPIN ALFA\/BETA","strength":"900 IU\/1.5ML","dosageForm":"INJECTABLE;SUBCUTANEOUS","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"GONAL-F RFF REDI-JECT","activeIngredients":"FOLLITROPIN ALFA\/BETA","strength":"150 IU\/0.25ML","dosageForm":"INJECTABLE;SUBCUTANEOUS","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"10\/16\/2013","submission":"SUPPL-36","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/021684s036lbl.pdf\"}]","notes":""},{"actionDate":"12\/18\/2007","submission":"SUPPL-7","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/021684s007lbl.pdf\"}]","notes":""},{"actionDate":"05\/25\/2004","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2004\\\/21684_gonal-f_lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"GONAL-F RFF REDI-JECT","submission":"FOLLITROPIN ALFA\/BETA","actionType":"300 IU\/0.5ML","submissionClassification":"INJECTABLE;SUBCUTANEOUS","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"GONAL-F RFF REDI-JECT","submission":"FOLLITROPIN ALFA\/BETA","actionType":"450 IU\/0.75ML","submissionClassification":"INJECTABLE;SUBCUTANEOUS","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"GONAL-F RFF REDI-JECT","submission":"FOLLITROPIN ALFA\/BETA","actionType":"900 IU\/1.5ML","submissionClassification":"INJECTABLE;SUBCUTANEOUS","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"GONAL-F RFF REDI-JECT","submission":"FOLLITROPIN ALFA\/BETA","actionType":"150 IU\/0.25ML","submissionClassification":"INJECTABLE;SUBCUTANEOUS","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 2013-10-16
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.